Outline
DOI: 10.3390/cancers16030661 ISSN: 2072-6694
Comment on Wu et al. Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma. Cancers 2023, 15, 2480
Manon Allaire, Dominique Thabut- Cancer Research
- Oncology
We read with great interest the original research conducted by Wu et al [...]
More from our Archive
- DOI: 10.3390/cancers16030661 2024Comment on Wu et al. Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma. Cancers 2023, 15, 2480Manon Allaire, Dominique Thabut
- DOI: 10.1002/cncr.35185 2024Association between treatment‐emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT studyFabio Piscaglia, Kenji Ikeda, Ann‐Lii Cheng, Masatoshi Kudo, Masafumi Ikeda, Valery Breder, Baek‐Yeol Ryoo, Kalgi Mody, Min Ren, Zahra Ramji, Max W. Sung
- DOI: 10.1002/cncr.35221 2024Safety and effectiveness of the radium‐223–taxane treatment sequence in patients with metastatic castration‐resistant prostate cancer in a global observational study (REASSURE)Celestia S. Higano, Sabina Dizdarevic, John Logue, Timothy Richardson, Saby George, Igle de Jong, Jeffrey J. Tomaszewski, Fred Saad, Kurt Miller, Jeffrey Meltzer, Per Sandström, Frank Verholen, Bertrand Tombal, Oliver Sartor
- DOI: 10.1002/cncr.35251 2024Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndromeAshley Dinh, J. Michael Savoy, Dimitrios P. Kontoyiannis, Koichi Takahashi, Ghayas C. Issa, Hagop M. Kantarjian, Courtney D. DiNardo, Caitlin R. Rausch
- DOI: 10.1002/cncr.35245 2024Challenges in clinical trials for high‐risk but curable prostate cancerTanya Barauskas Dorff, Alan H. Bryce
- DOI: 10.1002/gcc.23222 2024Near complete remission of an inoperable pancreatic acinar cell carcinoma after
BRAF ‐/MEK ‐inhibitor treatment—A case report and review of the literatureLennart von Fritsch, Nikolas von Bubnoff, Klaus Weber, Jutta Kirfel, Cleopatra Schreiber, Tobias Keck, Ulrich Wellner - DOI: 10.1002/ijc.34881 2024Occupational asbestos exposure and risk of esophageal cancer: A systematic review and meta‐analysisMonireh Sadat Seyyedsalehi, Paolo Boffetta
- DOI: 10.1002/ijc.34887 2024Environmental drivers of the rising incidence of early‐onset colorectal cancer in the United StatesJianjiu Chen, Mary Beth Terry, Piero Dalerba, Chin Hur, Jianhua Hu, Wan Yang
- DOI: 10.1002/ijc.34864 2024Long‐term exposure to air pollution and incidence of gastric and the upper aerodigestive tract cancers in a pooled European cohort: The
ELAPSE projectGabriele Nagel, Jie Chen, Andrea Jaensch, Lea Skodda, Sophia Rodopoulou, Maciej Strak, Kees de Hoogh, Zorana J. Andersen, Tom Bellander, Jørgen Brandt, Daniela Fecht, Francesco Forastiere, John Gulliver, Ole Hertel, Barbara Hoffmann, Ulla Arthur Hvidtfeldt, Klea Katsouyanni, Matthias Ketzel, Karin Leander, Patrik K. E. Magnusson, Göran Pershagen, Debora Rizzuto, Evangelia Samoli, Gianluca Severi, Massimo Stafoggia, Anne Tjønneland, Roel C. H. Vermeulen, Kathrin Wolf, Emanuel Zitt, Bert Brunekreef, Gerard Hoek, Ole Raaschou‐Nielsen, Gudrun Weinmayr - DOI: 10.1002/ijc.34877 2024Ovarian cancer survival in
sub‐Saharan Africa by human development index and histological subtypes: A population‐based registry studyMuluken Gizaw, Donald Maxwell Parkin, Ole Stöter, Phiona Bukirwa, Edom Seife, Gladys Chesumbai, Anne Korir, Biying Liu, Shyam S. Manraj, Guy Nda, Nontuthuzelo I. M. Somdyala, Eva Johanna Kantelhardt